News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
153 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38486)
2025 (19781)
Month
January (2946)
February (2976)
March (2714)
April (2913)
May (3636)
June (2415)
July (2093)
August (88)
Day
1 (94)
2 (82)
3 (85)
4 (29)
7 (42)
8 (101)
9 (110)
10 (103)
11 (63)
14 (67)
15 (78)
16 (100)
17 (95)
18 (54)
21 (66)
22 (92)
23 (152)
24 (97)
25 (112)
28 (70)
29 (128)
30 (120)
31 (153)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
Day
1
2
3
4
7
8
9
10
11
14
15
16
17
18
21
22
23
24
25
28
29
30
31
Earnings
Sanofi Confident Tariffs Will Have Limited Impact on Finances in 2025
For now, Sanofi’s U.S. inventory is insulating the company from a potential 15% tariff on drugs shipped from the EU.
July 31, 2025
·
2 min read
·
Nick Paul Taylor
Drug pricing
Trump Asks Big Pharmas to Move on Most Favored Nation Drug Pricing—Or Else
In 17 identical letters posted to his Truth Social account, the president said companies must lower their prices or the government ‘will deploy every tool in our arsenal to protect American families from continued drug pricing practices.’
July 31, 2025
·
2 min read
·
Dan Samorodnitsky
Earnings
Future of BMS’ Cobenfy Still in Limbo After Phase III Fail
Bristol Myers Squibb tested Cobenfy as an adjunctive treatment with atypical antipsychotics for schizophrenia in the Phase III ARISE study, which earlier this year failed to demonstrate significant symptom improvement.
July 31, 2025
·
2 min read
·
Tristan Manalac
Regulatory
FDA Issued Myeloma, Alzheimer’s Approvals in July but Rejected Two CGTs
The FDA greenlit multiple new drugs this month and issued some notable label expansions, including for Eli Lilly’s Kisunla. Meanwhile, the regulator turned away a cell therapy for Duchenne muscular dystrophy and a gene therapy for the rare disease Sanfilippo syndrome.
July 31, 2025
·
10 min read
·
Tristan Manalac
Press Releases
Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan
July 31, 2025
·
19 min read
Press Releases
Hologic Announces Financial Results for Third Quarter of Fiscal 2025
July 31, 2025
·
20 min read
Press Releases
Neurocrine Biosciences Reports Second Quarter 2025 Financial Results
July 31, 2025
·
17 min read
Press Releases
Mirum Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 6, 2025
July 31, 2025
·
2 min read
Press Releases
Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
July 31, 2025
·
1 min read
Press Releases
GRAIL to Present at Canaccord Genuity 45th Annual Growth Conference
July 31, 2025
·
1 min read
Previous
2 of 16
Next